Sign in Create account

Krsnaa Diagnostics Limited

Healthcare · Healthcare Services

NSE: KRSNAA BSE: 543328
₹559.95
▲ 6.35 (1.15%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
52/100
Moderate
Valuation
82/100
Undervalued
Momentum
68/100
Neutral

QVM read Cheap on its own multiples Quality Moderate, Valuation Undervalued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹1,816 Cr
PE (TTM)
18.4
Industry median 50.2 (44 companies)
Price to Book
1.9
PEG (TTM)
1.1
Institutions holding %
18.79%
FII + DII, latest filed period
Piotroski Score
4
Relative return vs Nifty50, qtr %
6.9
Relative return vs Sector, qtr %
4.5
Free Cash Flow
₹-76 Cr
as of March 31, 2026
Industry median ₹1 Cr (75 companies)
EPS Growth (YoY)
-20.00%
as of June 30, 2026
Industry median 13.27% (57 companies)
Net Profit Growth (TTM)
17.51%
as of June 30, 2026
Industry median 7.21% (57 companies)
Operating Revenue Growth (TTM)
4.59%
as of June 30, 2026
Industry median 12.82% (57 companies)
Profit Growth (YoY)
-19.13%
as of June 30, 2026
Industry median 8.53% (57 companies)
Revenue Growth (YoY)
19.96%
as of June 30, 2026
Industry median 18.84% (52 companies)
Current Ratio
2.68
as of March 31, 2026
Industry median 2.06 (74 companies)
Debt to Equity
0.55
as of March 31, 2026
Industry median 0.11 (62 companies)
Interest Coverage
4.01
as of June 30, 2026
Industry median 7.94 (57 companies)
Net Margin
7.51%
as of June 30, 2026
Industry median 9.88% (61 companies)
Operating Margin (EBIT)
17.20%
as of June 30, 2026
Industry median 17.21% (61 companies)
Operating Margin (TTM)
23.40%
as of June 30, 2026
Industry median 16.20% (59 companies)
Return on Assets
5.56%
as of March 31, 2026
Industry median 5.40% (58 companies)
Return on Capital Employed
10.64%
as of March 31, 2026
Industry median 10.44% (56 companies)
Return on Equity
10.35%
as of March 31, 2026
Industry median 10.16% (58 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 8 met
  • No Net profit is higher than a year earlier in each of the last 4 quarters
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • No Piotroski F-score is 7 or more (score 4)
  • No Debt to equity is below 0.5 (0.55)
  • No Return on equity is 15% or more (10.3%)
  • Yes Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

4 of 4 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)
  • Yes Insiders have not sold in the past 3 months (no open-market sale filed in the last 3 months)

Peer comparison

1 of 3 met
  • No 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

3 of 6 met
  • Yes Price sits in the Buy zone of its own historical PE range (Buy Zone)
  • Yes Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • Yes Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
1.1%
Low 543.0000 · High 564.4500
1W return
0.0%
Low 529.0000 · High 565.0000
1M return
1.1%
Low 525.0000 · High 598.0000
52W return
-27.5%
Low 515.0000 · High 848.1000
Lifetime High ₹1020.1500 (Nov. 25, 2024)
Lifetime Low ₹360.4000 (March 2, 2023)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish4
Bearish2
5D
552.2
10D
551.2
20D
551.8
50D
553.3
100D
565.9
200D
603.9

Delivery and volume

Day avg. delivery
60.5%
Week avg. delivery
52.2%
Month avg. delivery
26.2%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

555.80
Pivot
First resistance568.60
Second resistance577.25
Third resistance590.05
First support547.15
Second support534.35
Third support525.70
Day RSI53.7
Day MFI91.4
Day MACD-0.88
Day MACD signal-1.33

Beta

1M1.13
3M0.80
1Y0.90
3Y1.04

Price change analysis

↑ 1.1%
Over 1 Month
LowHigh
525.00598.00
↑ 1.7%
Over 3 Months
LowHigh
520.80598.00
↓ -0.2%
Over 6 Months
LowHigh
520.80630.35
↓ -27.5%
Over 1 Year
LowHigh
515.00848.10
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 18.4 (own history: 16.4–37.6)
Buy Zone

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹211 Cr
Net profit (June 30, 2026)
₹16 Cr
Basic EPS (June 30, 2026)
₹4.8800

Ranks #28 of 62 in Healthcare Services by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter27.11%
  • Mutual funds10.17%
  • FII/FPI4.28%
  • Other DII4.34%
  • Public54.10%

Largest holders

NameCategoryShares %Shares
RAJENDRA KHIVRAJ MUTHAPromoter24.7500%8029920
PHI CAPITAL TRUST - PHI CAPITAL GROWTH FUND - IPublic15.3700%4984967
TATA MUTUAL FUND - TATA SMALL CAP FUNDPublic8.0400%2608076
KRSNA DIAGNOSTICS (MUMBAI) PRIVATE LIMITEDPromoter2.3600%765685
AMICORP CAPITAL (MAURITIUS) LIMITEDPublic2.1800%706035

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 27.11% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings increased from 3.91% to 4.28% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings were unchanged at 10.17% in Jun 2026 qtr

8 mutual fund schemes also hold this stock.

All shareholding details →

Insider trading, SAST & pledges

All 13 insider trades, 4 SAST, 0 pledge events →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
31 Dec 2024 Krsna Diagnostics (Mumbai) Private Limited Promoter group Buy 0 ₹0
6 Jun 2024 KRSNA DIAGNOSTICS (MUMBAI) PRIVATE LIMITED Promoter group Buy 0 ₹0
14 Sep 2022 Krsna Diagnostics(Mumbai) PrivateLimited Promoter group Buy 0 ₹0
21 Feb 2022 Phi Capital Trust - Phi Capital Growth Fund - 1 Other Buy 0 ₹0
21 Feb 2022 Phi Capital Trust - Phi Capital Growth Fund - 1 Other Buy 0 ₹0
18 Feb 2022 Phi Capital Trust - Phi Capital Growth Fund - 1 Other Buy 0 ₹0
18 Feb 2022 Phi Capital Trust - Phi Capital Growth Fund - 1 Other Buy 0 ₹0
16 Feb 2022 Phi Capital Trust - Phi Capital Growth Fund - 1 Other Buy 0 ₹0
16 Feb 2022 Phi Capital Trust - Phi Capital Growth Fund - 1 Other Buy 0 ₹0
10 Feb 2022 Phi Capital Trust - Phi Capital Growth Fund - 1 Other Buy 0 ₹0

All insider and SAST disclosures →

Deals (Bulk & Block)

All 16 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
15 Jun 2026 HDFC LIFE INSURANCE COMPANY LIMITED Bulk Buy 280,585 539.2500 BSE
15 Jun 2026 HDFC LIFE INSURANCE COMPANY LIMITED Bulk Sell 280,585 539.2500 BSE
12 Jun 2024 KITARA PIIN 1104 Bulk Sell 372,000 600.6900 NSE
3 Oct 2023 MEDIMAZE SOLUTIONS PRIVATE LIMITED Block Sell 150,000 675.0000 NSE
3 Oct 2023 EAST LANE CAPITAL LLP Block Buy 150,000 675.0000 NSE
3 Oct 2023 MEDIMAZE SOLUTIONS PRIVATE LIMITED Block Sell 150,000 675.0000 NSE
3 Oct 2023 EAST LANE CAPITAL LLP Block Buy 150,000 675.0000 NSE
28 Sep 2023 MIV INVESTMENT SERVICES PRIVATE LIMITED Bulk Buy 159,909 675.0000 NSE
28 Sep 2023 INVESCO MUTUAL FUND Bulk Sell 195,305 675.0200 NSE
9 May 2023 SOMERSET INDUS HEALTHCARE FUND I LIMITED Bulk Sell 890,857 495.2700 NSE

All bulk and block deals →

Dividends

Full dividend history →
Last 12 months ₹2.00 per share
Dividend yield 0.36%
Ex-dateSubjectPer share (₹)Record date
— Final Dividend - Rs. - 2.0000 — —
18 Sep 2026 Dividend - Rs 2 Per Share 2.0000 18 Sep 2026
12 Sep 2025 Dividend - Rs 2.75 Per Share 2.7500 12 Sep 2025
13 Sep 2024 Dividend - Rs 2.50 Per Share 2.5000 13 Sep 2024
15 Sep 2023 Dividend - Rs 2.75 Per Share 2.7500 15 Sep 2023
15 Sep 2022 Dividend - Rs 2.50 Per Share 2.5000 16 Sep 2022

Corporate Actions

Full history (8 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
13 Sep 2024OTHERAnnual General Meeting
15 Sep 2023OTHERAnnual General Meeting

All corporate actions →

Board Meetings

View board meeting history →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
13 Aug 2026 Financial Results/Fund Raising Yes
25 May 2026 Financial Results/Dividend Yes
5 Feb 2026 Financial Results Yes
12 Dec 2025 Fund Raising —
7 Nov 2025 Financial Results Yes

Corporate Announcements

All 646 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
30 Sep 2026 AGM/EGM Krsnaa Diagnostics Ltd - 543328 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
30 Sep 2026 Company Update Krsnaa Diagnostics Ltd - 543328 - Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Appointment Of Statutory Auditor
30 Sep 2026 Shareholders meeting Submission of Revised Voting Results.
30 Sep 2026 General Updates Krsnaa Diagnostics Limited has informed the Exchange about General Updates
30 Sep 2026 Shareholders meeting Krsnaa Diagnostics Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 28, 2026. Further, the company has informed the Exchange regarding voting results.
30 Sep 2026 AGM/EGM Krsnaa Diagnostics Ltd - 543328 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
28 Sep 2026 AGM/EGM Krsnaa Diagnostics Ltd - 543328 - Shareholder Meeting / Postal Ballot-Outcome of AGM
28 Sep 2026 General Updates Krsnaa Diagnostics Limited has informed the Exchange about General Updates
28 Sep 2026 Shareholders meeting Krsnaa Diagnostics Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 28, 2026
28 Sep 2026 Company Update Krsnaa Diagnostics Ltd - 543328 - Announcement Under Regulation 30 (6) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Healthy liquidity (Current Ratio 2.68)
  • Strong revenue growth YoY (20.0%)

Weaknesses

  • Declining profit YoY (-19.1%)

Opportunities

Data unavailable.

Threats

  • Down 27.5% over the past year

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Krsnaa Diagnostics Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.